At a glance
| Abbreviation | HuGHV4, EBV |
|---|---|
| ICTV species | Lymphocryptovirus humangamma4 |
| Family | Orthoherpesviridae |
| Baltimore class | I — dsDNA |
| Human infection | Human infection recorded; pattern not classified |
Also called: human gammaherpesvirus 4; Lymphocryptovirus human gamma 4; Lymphocryptovirus humangamma4
Duplodnaviria › Peploviricota › Herviviricetes › Herpesvirales › Orthoherpesviridae › Lymphocryptovirus
What it is
Taxonomy copied from ICTV MSL41.v1 / VMR_MSL41.v1.20260729.xlsx. These ranks are not hand-edited; a correction means re-running the fetch against a newer release.
| Realm | Duplodnaviria |
|---|---|
| Kingdom | Heunggongvirae |
| Phylum | Peploviricota |
| Class | Herviviricetes |
| Order | Herpesvirales |
| Family | Orthoherpesviridae |
| Subfamily | Gammaherpesvirinae |
| Genus | Lymphocryptovirus |
| ICTV identifier | ICTV19710173 |
| NCBI taxon | 3050299 |
| Exemplar isolate | AJ507799 |
Host evidence
- human: 6,446 GenBank records
- dog: 2 GenBank records (flagged for review)
Counts of nucleotide records annotated with that host. Evidence of provenance, not a statement of host range.
Where it occurs
Not searched yet. No country-level occurrence data has been curated for this virus. The WHO reported-case data on this site covers a limited set of diseases; a virus outside it gets no map rather than an empty one.
What it does
Not searched yet. Burden, severity and transmissibility figures have not been curated for this virus yet. When they are, each will carry the exact sentence from its source.
Vaccines
Nothing in use found in the sources searched. That is not the same as nothing existing; see the methods page for what was searched.
In development
| Name | Developer | Platform | Use | Stage | Jurisdictions | Trials | Source |
|---|---|---|---|---|---|---|---|
| mRNA-1189 | ModernaTX, Inc. | mrna | Routine immunisation | Phase 2 | Not searched yet | NCT05164094 NCT07478952 | candidateId ctgov-mrna-1189-modernatx-inc (targetDisease 'EBV'); stage |
| mRNA-1195.1 | ModernaTX, Inc. | mrna | Routine immunisation | Phase 1 | Not searched yet | NCT05831111 | candidateId ctgov-mrna-1195-1-modernatx-inc (targetDisease 'EBV'); sta |
| V350 (V350A / V350B, EBV vaccine) | Merck Sharp & Dohme LLC | Not searched yet | Routine immunisation | Phase 1 | Not searched yet | NCT06655324 | candidateId ctgov-v350a-merck-sharp-dohme-llc (targetDisease 'Epstein- |
Antivirals
Not searched yet. No US-approved antiviral for this virus was found in the openFDA drug label endpoint. Only US labels were searched, and only drugs the FDA classes as antivirals.
Antibodies and immune globulins
Not searched yet. No US-approved antiviral antibody for this virus was found in the openFDA drug label endpoint.
Approval status is not a treatment recommendation. Dosing and eligibility are on the label and in national guidelines. This page does not give medical advice and does not render dosing. A development stage is not a measure of how well something works.
Related on this site
- Vaccine pipeline — candidates listed under “EBV”
- Other Orthoherpesviridae viruses
- Veterinary vaccines for this virus — animals, kept separate on purpose